Teva to acquire Bentley Pharmaceuticals

01 Apr 2008

1

Israel's Teva Pharmaceutical Industries Ltd. is acquiring Bentley Pharmaceuticals Inc, for Approximately $360 million.
 
The two companies have announced having entered into a definitive agreement under which Teva will acquire Bentley following the spin-off of Bentley's drug delivery business to its shareholders, which Bentley announced on 23 October 2007.

Shareholders of Bentley will receive approximately $15.02 per share in cash in the acquisition, and also will receive shares of CPEX Pharmaceuticals Inc. pursuant to the spin-off, which will occur before the acquisition.

The boards of directors of both companies have unanimously approved the transaction.

Closing is subject to usual conditions, including completion of the proposed spin-off of Bentley's drug delivery business, antitrust approvals, the approval of Bentley's shareholders, and other customary closing conditions.

The transaction is expected to close in the third quarter of 2008.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more